Michael James Mullen

Nessuna posizione attualmente

65 anni

Health Technology

Finance

Commercial Services

Profilo

Mr. Michael J.
Mullen, CPA, is Independent Director at Alseres Pharmaceuticals, Inc. He is on the Board of Directors at Alseres Pharmaceuticals, Inc. Mr. Mullen was previously employed as Chief Financial Officer by Rapid Micro Biosystems, Inc., Chief Financial Officer by Magellan Biosciences Point-Of-Care, Inc., Chief Financial Officer by JMH Capital LLC, Chief Financial Officer by Magellan Discovery Technologies LLC, Chief Financial Officer by PerkinElmer, Inc., Chief Financial Officer & Controller by Thermo Optek Corp., Chief Financial Officer by Valeritas, Inc., and a Principal by Arthur Andersen LLP.
He received his undergraduate degree from James Madison University.

Precedenti posizioni note di Michael James Mullen

Società	Posizione	Fine
Magellan Diagnostics, Inc. Magellan Diagnostics, Inc. Medical SpecialtiesHealth Technology Magellan Diagnostics, Inc. develops diagnostic laboratory products. It products include LeadCare II System and LeadCare Ultra. The firm's services encompass blood lead and zinc protoporphyrin analysis. The company was founded in 1968 and is headquartered in North Billerica, MA.	Direttore Finanziario/CFO	01/10/2009
JMH Capital LLC JMH Capital LLC Investment ManagersFinance JMH Capital LLC (JMH Capital) is a private equity firm founded in 2003 by Michael James Mullen, Anthony W. Brooke, John A. Nies, and Scott D. Steele. The firm is headquartered in Boston, Massachusetts.	Fondatore	01/03/2006
Magellan Discovery Technologies LLC	Direttore Finanziario/CFO	01/12/2002
REVVITY, INC.	Direttore Finanziario/CFO	01/09/2000
Thermo Optek Corp. Thermo Optek Corp. Medical SpecialtiesHealth Technology Part of Thermo Fisher Scientific, Inc., Thermo Optek Corp. makes analytical and environmental monitoring instruments. The company is based in Waltham, MA.	Direttore Finanziario/CFO	01/03/1999

Vedi nel dettaglio l'esperienza di Michael James Mullen

Formazione di Michael James Mullen

James Madison University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Michael James Mullen

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	3
ALSERES PHARMACEUTICALS, INC.	Health Technology
REVVITY, INC.	Health Technology
RAPID MICRO BIOSYSTEMS, INC.	Producer Manufacturing

Aziende private	6
JMH Capital LLC JMH Capital LLC Investment ManagersFinance JMH Capital LLC (JMH Capital) is a private equity firm founded in 2003 by Michael James Mullen, Anthony W. Brooke, John A. Nies, and Scott D. Steele. The firm is headquartered in Boston, Massachusetts.	Finance
Arthur Andersen LLP Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL.	Commercial Services
Magellan Diagnostics, Inc. Magellan Diagnostics, Inc. Medical SpecialtiesHealth Technology Magellan Diagnostics, Inc. develops diagnostic laboratory products. It products include LeadCare II System and LeadCare Ultra. The firm's services encompass blood lead and zinc protoporphyrin analysis. The company was founded in 1968 and is headquartered in North Billerica, MA.	Health Technology
Magellan Discovery Technologies LLC
Thermo Optek Corp. Thermo Optek Corp. Medical SpecialtiesHealth Technology Part of Thermo Fisher Scientific, Inc., Thermo Optek Corp. makes analytical and environmental monitoring instruments. The company is based in Waltham, MA.	Health Technology
Valeritas, Inc. Valeritas, Inc. Medical SpecialtiesHealth Technology Valeritas, Inc. engages in the development and commercialization of drug delivery solutions for the treatment of diabetes. Its product, V-Go wearable insulin delivery device, which enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery by using one type of insulin at a continuous preset basal rate over a 24-hour period and provides on-demand bolus dosing for meals and snacks. The company was founded on August 2, 2006 and is headquartered in Bridgewater, NJ.	Health Technology

Vedi le connessioni aziendali